|
|
||||||||
Department of Kinesiology, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1
Submitted 5 September 2003 ; accepted in final form 9 January 2004
| ABSTRACT |
|---|
|
|
|---|
O2 peak) observed during progressive exercise in hypoxia (H). Nine untrained men (20.7 ± 0.42 yr) performed progressive cycle exercise to fatigue on two occasions, namely during N (inspired oxygen fraction = 0.21) and during H (inspired oxygen fraction = 0.14). Tissue extracted from the vastus lateralis before exercise and at power output corresponding to 50 and 70% of
O2 peak (as determined during N) and at fatigue was used to investigate changes in homogenate SR Ca2+-cycling properties. Exercise in H compared with N resulted in a 19 and 21% lower (P < 0.05) POpeak and
O2 peak, respectively. During progressive exercise in N, Ca2+-ATPase kinetics, as determined by maximal activity, the Hill coefficient, and the Ca2+ concentration at one-half maximal activity were not altered. However, reductions with exercise in N were noted in Ca2+ uptake (before exercise = 357 ± 29 µmol·min1·g protein1; at fatigue = 306 ± 26 µmol·min1·g protein1; P < 0.05) when measured at free Ca2+ concentration of 2 µM and in phase 2 Ca2+ release (before exercise = 716 ± 33 µmol·min1·g protein1; at fatigue = 500 ± 53 µmol·min1·g protein1; P < 0.05) when measured in vitro in whole muscle homogenates. No differences were noted between N and H conditions at comparable power output or at fatigue. It is concluded that, although structural changes in SR Ca2+-cycling proteins may explain fatigue during progressive exercise in N, they cannot explain the lower POpeak and
O2 peak observed during H. calcium cycling; muscle; normoxia; fatigue
The SR, an intracellular membranous network that envelopes the myofibrils, regulates [Ca2+]f levels by selective control of the rate of Ca2+ release from Ca2+ stored inside the SR and by the rate of Ca2+ uptake (4). Ca2+ release depends on the open state of the Ca2+-release channels (CRC) or ryanodine receptors, an
450-kDa protein embedded in the SR membrane, most of which is localized to the terminal cisternae, which is in close apposition to the T tubules (12). It is now generally acknowledged that, in skeletal muscle, the action potentials that are conducted along the sarcolemma and into the T tubule result in a physical-chemical coupling between the T tubules and the CRC and opening of the CRC, enabling the rapid release of Ca2+ (4). The sequestration of [Ca2+]f back into the SR is controlled by the Ca2+-ATPase, an
110-kDa protein located primarily in the longitudinal SR, which uses the energy from the hydrolysis of ATP to pump Ca2+ against its concentration gradient for storage in the SR (27). Increases in [Ca2+]f are a potent stimulus for increasing the activity of Ca2+-ATPase and, consequently, the rate of Ca2+ uptake into the SR (32).
The possibility that disturbances in SR Ca2+ cycling may be involved in fatigue during submaximal exercise is also supported by several studies that have demonstrated reductions in both Ca2+-ATPase activity (6, 7, 14), Ca2+ uptake (6, 7), and Ca2+ release (10) in both rat and human locomotor muscles. Information is emerging to indicate that the disturbances in Ca2+ uptake and Ca2+ release are mediated by structural adaptations in the Ca2+-ATPase enzyme (26) and the CRC (9) secondary to oxidation and/or nitrosylation mediated by reactive O2 species (ROS) (23, 24).
During intense dynamic exercise, increases in the rate of Ca2+ cycling in the muscle cell and consequently in the rate of Ca2+ release and Ca2+ uptake are necessary to realize increases in PO. A disturbance in either Ca2+ release and/or Ca2+ uptake would be expected to alter the [Ca2+]f integral and disrupt force profiles (1).
Intuitively, one might expect that supramaximal fatiguing exercise would produce even more dramatic reductions in SR Ca2+ cycling. There is evidence to support this idea since pronounced reductions in Ca2+-ATPase activity and Ca2+ uptake have been reported with exhaustive running in horses (8) and rats (52) and with intense knee extensions in humans (13, 25). Pronounced depressions in SR Ca2+ release have also been reported (25, 43). However, not all studies are consistent, because reports have been published indicating no change in Ca2+-ATPase activity (19, 31) and in Ca2+ uptake (18, 31) with intense, repetitive contractions.
Progressive dynamic exercise to fatigue is commonly employed to assess peak aerobic power [peak O2 consumption (
O2 peak)], one of the most important properties in applied physiology. However, it is unclear whether the peak mechanical power output (POpeak) attained is limited by a failure in SR Ca2+ cycling.
Hypoxia is known to result in a reduction in POpeak and
O2 peak during progressive exercise to fatigue (15, 33). It is generally believed that the reduction in
O2 peak observed in hypoxia occurs because of limitations in O2 availability to the mitochondria, secondary to reductions in arterial O2 content and O2 delivery to working muscles (51). However, this interpretation could be simplistic because it assumes that the viability of the E-C processes in muscle are protected, allowing power output (PO) to increase and available O2 to be fully utilized for ATP regeneration to contribute the increasing demands of the cellular ATPases involved in E-C. It is possible that the reverse may be true, namely that E-C failure may occur prematurely, resulting in fatigue and an inability to utilize available O2 for oxidative phosphorylation (OxPhos).
The purpose of this study was to investigate the effects of progressive cycle exercise in normoxia and hypoxia on muscle SR function. We have hypothesized that progressive reductions in Ca2+-ATPase activity, Ca2+ uptake, and Ca2+ release would occur with increases in PO. We have also postulated that, at similar PO, the depression in the Ca2+-cycling properties would be more pronounced in hypoxia compared with normoxia. However, at fatigue in normoxia vs. hypoxia, the disturbances would be comparable, consistent with the lower POpeak and
O2 peak typically observed with hypoxia.
| METHODS |
|---|
|
|
|---|
Experimental design.
To investigate the effects of progressive cycle exercise during normoxia and hypoxia, a randomized cross-over design was employed. In this design, all participants completed each condition within a minimum of 3 wk between test sessions for each individual. At least 1 wk before the beginning of the experiment, volunteers reported to the laboratory and completed a preliminary incremental exercise test to fatigue during normoxia. This test was used to ensure a normal response to exercise and to verify that a maximal or near maximal physiological response could be achieved. For all tests, fatigue was defined as an inability to maintain pedal frequency at
60 revolutions/min, even with verbal encouragement.
During the actual test days, the participants reported to the laboratory
60 min before the beginning of the exercise test. During this time, the individual was prepared for muscle biopsies. For tissue sampling,
0.5 ml of a local anaesthetic (2% xylocaine) was administered to selected sites over the vastus lateralis muscles and then prepared for needle biopsies (5). For the test in normoxia, four separate sites were prepared balanced between the two legs. For the test in hypoxia, three separate sites were prepared, two in one leg and one in the other. After the preliminary preparations, the volunteers reported to the exercise testing area, mounted an electrically braked cycle ergometer (Siemens Elma 380 B), and were prepared for heart rate and respiratory gas-exchange measurements (21). These measurements were obtained continuously before and throughout exercise.
For the test conducted in normoxia, the participant breathed room air for 15 min before the beginning of exercise (Fig. 1). The exercise protocol consisted of 4 min of cycling at 25 W followed by step increases in work rate of 15 W/min until fatigue (Fig. 1). Before the start of cycling, resting tissue samples were obtained. In addition, tissue samples were obtained at mechanical POs equivalent to
50 and 70%
O2 peak as determined in normoxia and at fatigue. To obtain the exercise biopsies, the cycling was briefly interrupted and the tissue quickly extracted from previously prepared sites. The order of biopsies was alternated between legs.
|
O2 peak as determined in normoxia) and at fatigue. The final exercise biopsy at fatigue in hypoxia was obtained at a PO equivalent to
80%
O2 peak in normoxia. As with the nomoxia test, the participant sat quietly on the cycle and breathed room air for 15 min before the resting tissue sample was obtained. However, unlike the normoxia condition, the volunteer breathed a hypoxic gas mixture after tissue sampling from a Tissot tank, which was used as a gas reservoir. The gas mixture, containing 14% O2 and the balance N2, was continuously provided by premixed gas cylinders. After the tissue sampling, the hypoxic gas mixture was breathed continuously during the exercise. The rate of flow of gas into the Tissot was continuously adjusted to maintain an adequate supply of gas. Identical procedures were employed for normoxia, except that room air was used. On a given experimental day, the participant was instructed to consume a light snack consisting of juices. Approximately 3 h before reporting to the laboratory, a meal-replacement beverage was provided (Ensure; 250 kcal; 61, 24, and 15% Kcals from carbohydrates, lipids, and proteins, respectively). This procedure was utilized to standardize the nutritional intake before the two test conditions. Before testing, water intake was not controlled. All volunteers were instructed not to consume alcohol and caffeine nor to engage in heavy exercise for at least 24 h before testing. For each subject, the two exercise tests were performed at approximately the same time of day. For respiratory gas collection, an open-circuit system was employed as previously described (21). The electronic cycle was calibrated on a daily basis, and care was taken to ensure that the seat height was standardized for each volunteer between tests. Average environmental conditions in the testing room were not different between conditions and ranged between 50 and 60% relative humidity and 21 and 22°C in temperature.
Measurement of SR function.
Immediately after extraction of the tissue, homogenates were prepared and stored at 80°C until analyses of Ca2+-ATPase activity, Ca2+ uptake, and Ca2+ release. Homogenates, prepared under ice-cold conditions, consisted of 11:1 (vol/wt) dilution of buffer containing (in mM) 250 sucrose, 5 HEPES, 10 NaN3, and 0.2 PMSF (pH 7.5). Tissue (
3040 mg) was homogenized by using a handheld glass homogenizer (Kontes, Duall 20) (29). Once prepared, the homogenate was separated into a number of aliquots and quick frozen in liquid N2 before storage. On a given analytical day and just before analysis, aliquots were thawed and processed for specific measurements. For a given property, duplicate measurements were performed. Care was taken to ensure that a complete set of measurements were made on all tissues for a given participant during a specific analytical session.
Ca2+-ATPase activity.
Ca2+-ATPase activity was assessed spectrophotmetrically using the basic procedures developed by Simonides and van Hardeveld (40), as modified in our laboratory (45). The reaction buffer contained (in mM) 200 KC1, 20 HEPES, 15 Mg Cl2, 1 EGTA, 10 NaN3, 5 ATP, and 10 phosphoenolpyruvate. The pH of the buffer was adjusted to 7.0 at 37°C. Just before the reaction was started, 18 U/ml lactate dehydrogenase, 18 U/ml pyruvate kinase, 0.3 mM NADH, and 25 µl of homogenate were added to a cuvette containing 1 ml of reaction buffer. One micromolar Ca2+ ionophone A-23187 (Sigma C-7522) was also added to prevent intraluminal Ca2+ accumulation in SR and inhibition of Ca2+-ATPase activity (40). Assays were performed in duplicate at 37°C and 340 nm (Shimadzu UV 160) using
1 mg wet wt of tissue per assay. After the baseline absorbance of NADH was recorded for
1 min, the reaction was initiated by adding 1 µl of 100 mM CaCl2 and monitored for
2 min.
Maximal Ca2+-ATPase activity and Ca2+ dependency of Ca2+-ATPase activity were measured using a 0.5-µl addition of 100 mM CaCl2. The additions were continued until a plateau and subsequent decline in Ca2+-ATPase activity were observed. Basal or Mg2+-ATPase activity was determined in the presence of 40 µM of the specific inhibitor of the Ca2+-ATPase cyclopiazonic acid (38). Ca2+-ATPase activity is based on the difference between the total and basal ATPase activities. The validity of SR Ca2+-ATPase activity assay has been previously established in whole muscle homogenates (34, 40). It should be emphasized that a potential limitation of the regenerating assay employed is the possible loss of ADP to AMP via the myokinase reaction. However, we have shown using a myokinase inhibitor (AP5A) that Ca2+-ATPase activity is unaffected (unpublished observations).
Measurement of [Ca2+]f, which is used to assess Ca2+ dependency of the Ca2+-ATPase reaction, was assessed with dual-wave spectrofluorometry and the Ca2+ fluorescent dye indo 1 according to procedures previously detailed (46, 48). In summary, the measurement of [Ca2+]f is based on the difference in maximal emission wavelengths between the Ca2+-bound-indo 1 complex and the Ca2+-free indo 1 complex. An excitation wavelength of 355 nm and the emission maxima were recorded at 405 and 485 nm for Ca2+-bound- and Ca2+-free indo 1. Felix software (Photon Technology International) was used to calculate the ionized Ca2+ concentration according of Eq 2.5 of Grynkiewicz et al. (17). The dissociation constant that was used for the interaction between Ca2+ and indo 1 was 250 nM (17). It should be emphasized that in homogenates the actual dissociation constant can be significantly affected by the protein composition. As such, given the uncertainty as to the true value of the dissociation constant, the pCa values used throughout the text are only apparent.
The kinetic properties of the Ca2+-ATPase activity that were measured included the maximal activity (Vmax), the [Ca2+]f needed to obtain half-Vmax (Ca50), and the Hill coefficient (nH). To obtain these properties, Ca2+-ATPase activity was plotted against the negative logarithm of [Ca2+]f (pCa). Vmax represented the peak value, Ca50 represented the [Ca2+]f obtained from a sigmoid fit of the data that yields 50% of Vmax, and nH was obtained through nonlinear regression with computer software (GraphPad Software) by using a portion of the curve that corresponded to between 20 and 80% of Vmax. These procedures have been described in recent papers from our laboratory (37, 49).
Ca2+ uptake and Ca2+ release.
Both Ca2+ uptake and Ca2+ release were measured during the same assay. In general, the procedure employed involved using the Ca2+ fluorescent dye indo 1 according to the methods of O'Brien et al. (30) as modified by our group (46). The reaction buffer for these assays contained (in mM) 200 KC1, 20 HEPES, 15 MgCl2, 10 NaN3, 0.005 N,N,N1,N1-tetrakis(2-pyridlymethyl)-ethylenediamine, 5 oxalate, and 10 phosphoenolpyruvate. Before each assay, 1.5 µM indo 1, 18 U/ml lactate dehydrogenase, and 18 U/ml pyruvate kinase were added to 2 ml of reaction buffer. In addition, 2.5 µl of CaCl2 (10 mM) were added to the cuvette to produce a consistent starting [Ca2+]f of
3.5 µM. After a constant [Ca2+]f was achieved, 5 mM ATP was added to the cuvette to initiate Ca2+ uptake. Ca2+-uptake rates were assessed over a range of [Ca2+]f by using a single assay. [Ca2+]f was measured as described earlier. The maximal rate of Ca2+ uptake for each [Ca2+]f was determined by differentiating the linear fit curve using four concentrations of cytosolic free Ca2+, namely 500, 1,000, 1,500, and 2,000 µM. We have found that with this procedure there is a rapid initial drop in [Ca2+]f. A large component of the initial drop in [Ca2+]f has been credited to the binding of Ca2+ with proteins in the homogenates (34). As a consequence, the initial changes in [Ca2+]f were not used in the calculation of Ca2+ uptake (34).
Ca2+ release was measured immediately after Ca2+ uptake according to the general procedures of Ruell et al. (34). However, unlike Ruell et al., who employed AgNO3, we have employed 4-chloro-m-cresol (4-CMC). We have recently shown that effects of 4-CMC are specific to the CRC and do not cause Ca2+-ATPase pump reversal, as was noted for AgNO3 (47). To assess Ca2+-release rates, 20 µM of 4-CMC was added to the cuvette after [Ca2+]f declined to a plateau after the measurement of Ca2+ uptake. We have found that a biphasic Ca2+ release can be distinguished, an early release, which we have labeled phase 1, and a slower, more delayed release, which we have labeled phase 2 (47). Maximal release rates for each phase were calculated using the same method as for Ca2+ uptake and differentiating using a linear-fit curve.
It should be noted that, because Ca2+ uptake and Ca2+ release were measured in the same assay, the reaction buffers were the same. It is now possible that optimal assay conditions may vary with the property measured. As an example, 15 mM MgCl2 was used for both Ca2+ uptake and Ca2+ release. In the case of Ca2+ release, optimal MgCl2 levels appear to be between 20 and 30 mM (unpublished observations).
For all SR properties, protein was determined by the method of Lowry as modified by Schacterle and Pollock (36). This involved separate protein assessments in homogenate used for Ca2+-ATPase activity and in homogenates used for Ca2+-uptake and Ca2+-release assays. There were no significant differences in protein levels between normoxic and hypoxic conditions. The coefficients of variation for duplicate measurements for Ca2+ uptake and Ca2+-ATPase activity were 7.6 ± 0.9 and 7.9 ± 2.2%, respectively. Only single measurements were used for Ca2+-release determinations.
Statistics. Group data are expressed throughout the text as means ± SE. To examine the effects of progressive exercise and O2 condition on SR function, linear regression techniques were employed, and the slope of the regression line for each condition was established. Student's t-tests were used to examine differences between slopes and, hence, conditions. Conventional two-way ANOVA procedures were not possible because of the unbalanced nature of the tissue-sampling schedule (see Fig. 1). Where only one variable was of interest (such as during exercise in normoxia or hypoxia), a one-way ANOVA with repeated measures was employed. Two-way ANOVA procedures were used to examine the effects of condition and exercise on the gas-exchange properties. We have also performed a secondary analysis, using two-way ANOVA procedures, to determine the effects of exercise and O2 condition on SR properties using matched samples. Where significance was found, Newman-Keuls techniques were applied to locate differences between specific means. The significance level was set at P < 0.05 for all comparisons.
| RESULTS |
|---|
|
|
|---|
19% lower than the value obtained during normoxia. As expected,
O2 peak was also reduced with hypoxia compared with normoxia (4.07 ± 0.15 vs. 3.21 ± 0.11 l/min, respectively).
Measurements of exchange during normoxia and hypoxia were obtained at matching POs of 137 ± 51, 214 ± 6.9, and 250 ± 7 W (Table 1). These data indicated that no differences existed in
O2 (l/min) between normoxia and hypoxia at corresponding POs. As expected, CO2 production, expiratory minute volume (BTPS), and respiratory exchange ratio were all higher during exercise in hypoxia compared with normoxia. In the case of CO2 production and expiratory minute volume, the differences were observed both at rest and during each PO.
|
O2 at comparable POs, the SR changes have been plotted against
O2. Our results indicated that, during progressive exercise in normoxia, no alterations were observed in Vmax, nH, or Ca50 (Table 2). Similarly, we found no effect of exercise and hypoxia on these properties. No differences were found between normoxia and hypoxia. Basal ATPase was not altered by either exercise or O2 condition. For basal ATPase (µmol·min1·g protein1), the values for normoxia were 36 ± 6, 39 ± 7, 38 ± 4, and 36 ± 4 for rest and 50%
O2 peak (N), 70%
O2 peak (N), and fatigue, respectively. For hypoxia, the values were 44 ± 5, 44 ± 3, and 41 ± 4 for rest, 50%
O2 peak (N), and fatigue, respectively. The Ca2+-dependent Ca2+-ATPase activities for a typical volunteer are plotted in Fig. 2.
|
|
|
|
O2 peak (normoxia), which was greater than fatigue. For hypoxia, before exercise was >50%
O2 peak (normoxia), which was greater than fatigue. No differences in slopes were observed between normoxia and hypoxia for either phase.
|
|
| DISCUSSION |
|---|
|
|
|---|
O2 peak test and that these disturbances would be further exaggerated when the exercise is performed in hypoxia. Our results clearly demonstrate a reduction in both Ca2+ uptake and Ca2+ release during exercise in normoxia. In the case of Ca2+ uptake, the reduction, which amounted to
14%, was only observed at fatigue. In the case of Ca2+ release (phase 2), exercise intensity-dependent reductions were observed, which amounted to
30% at fatigue. We have found that exercise in hypoxia failed to exacerbate the decreases in Ca2+ uptake and Ca2+ release that occurred during submaximal exercise. At fatigue with both normoxia and hypoxia, no differences were observed in the Ca2+-cycling properties. Given that the exercise time and PO were reduced in hypoxia compared with normoxia, the existence of similar changes in Ca2+ uptake and Ca2+ release suggests a failure in SR function as a common mechanism. Although reductions in Ca2+ cycling, Ca2+ uptake, and Ca2+ release with various exercise protocols have previously been shown to occur in humans (6, 25, 45), our study appears to be the first to demonstrate disturbances in SR function during progressive exercise. The reduction in Ca2+ uptake that we have observed in vitro appears to occur in the absence of changes in the kinetic properties of the Ca2+-ATPase because we could find no effect of exercise on Vmax, nH, or Ca50 either during normoxia or hypoxia. This was unexpected because previous studies in both animals (7) and humans (6) have reported parallel reductions in Vmax and Ca2+ uptake with prolonged exercise. However, there are reports where changes in Ca2+ uptake are dissociated from changes in Ca2+-ATPase activity (3, 11). Our results are similar to a previous study (19) in humans investigating the effects of intense dynamic knee extensor exercise in which reductions in Ca2+ uptake occurred in the absence of changes in Ca2+-ATPase activity.
At present, it is not clear what the underlying mechanism is to explain the dissociation between these two properties that has been observed. Several possibilities exist. First, it should be emphasized that the assays for Ca2+ uptake and Ca2+-ATPase activity are performed under different conditions. In the case of Ca2+ uptake, oxalate is employed to bind Ca2+ in the lumen of the SR (28). Oxalate has been previously shown to increase Ca2+-uptake rates in homogenates, conceivably by preventing the inhibitory effects of increases in luminal [Ca2+]f (22). For the measurement of Ca2+-ATPase activity, the Ca2+ ionophone A23187 [GenBank] was employed, which prevents the accumulation of Ca2+ in the lumen of the SR and causes back inhibition of Ca2+-ATPase activity by allowing diffusion of Ca2+ out of the SR (40). The reduction in Ca2+ uptake that we have observed in exercise in the absence of changes in Ca2+-ATPase activity could occur as a result of slippage of the Ca2+-ATPase during the catalytic cycle of Ca2+ transport. This has been observed to occur as a result of sarcolipin, a small peptide located in association with the Ca2+-ATPase (42). How a similar effect would be induced by progressive exercise is unclear. It should be emphasized that the reductions in Ca2+ uptake that we have observed at fatigue were relatively modest and insufficient to significantly alter the coupling ratio between Ca2+-ATPase activity and Ca2+ uptake. Because coupling ratios were not altered with exercise either during normoxia or hypoxia, it would appear that the energy costs per unit of Ca2+ transport into the SR were unchanged (4, 27).
The most pronounced effect of progressive exercise on the SR function was noted for Ca2+ release. Reductions in Ca2+ release assessed in vitro have been commonly observed with a variety of exercise protocols (6, 9, 19, 25, 31). Reductions in Ca2+ release appear to be associated with a reduction in [3H]ryanodine binding (9), which has been used as evidence to support the hypothesis that structural damage to the CRC occurs (9). [3H]ryanodine is known to bind specifically to a 245-amino acid-long polypetide, which is located in a region encompassing most of the myoplasmic loop-2, which is closely associated with the transmembrane segments M5 of the CRC (12). This has been identified as the putative functional domain of the CRC, and as a consequence [3H]ryanodine binding reflects the open state of the channels (10).
In this study, we have used 4-CMC as the CRC-releasing agent. The selection of 4-CMC, instead of AgNO3, which has previously been commonly employed as a releasing agent (9), was based on a recent publication by our group (47). In that study, our laboratory found that AgNO3, in contrast to 4-CMC, induces Ca2+ release by acting on both the CRC and Ca2+-ATPase. We have also been able to identify two phases of Ca2+ release, phase 1 and phase 2. We have observed that only reductions in phase 2 were observed with exercise. At present, the physiological significance of this observation is not clear because, in our in vitro system, the Ca2+-release rates occur at a much slower rate than observed in single-fiber and isolated-channel preparations (9). Our homogenate system is based on a preparation from whole muscle and consequently contains all of the proteins regulating SR behavior. This factor would appear important in the regulation of Ca2+ release and explain, at least in part, differences that exist between the homogenate system and other preparations, such as isolated vesicles and single channels. It must be acknowledged, however, that, regardless of the preparation, some functional alterations could be expected during the homogenization process.
The reduction in Ca2+ release that we have observed with our progressive exercise protocol probably results from a decrease in the number of functional CRC (9). Although definitive evidence is lacking, it is strongly suspected that oxidative and/or nitrosylative processes mediated by ROS are involved in the structural modifications to the CRC that occur (9, 44). It would be expected that ROS would accumulate during progressive exercise given the increase in OxPhos and the increase in inosine 5'-monophosphate (IMP) that occurs (16). It has been estimated that 24% of OxPhos results in ROS generation by the election transport system (39, 41). In addition, the conversion of IMP to hypoxanthine and xanthine by xanthine oxidase also increases ROS formation (39, 41). Conceivably, the increase in ROS generation by xanthine oxidase during exercise would occur given the larger IMP accumulation (35). It is possible that the increase in ROS was insufficient to result in a greater reduction in Ca2+ release with hypoxia compared with normoxia. At present, it is not clear why reductions in Ca2+-ATPase activities during progressive exercise did not occur in either normoxia or hypoxia, given the apparent sensitivity of this enzyme to ROS (23).
A potential factor that could influence our measurements of the SR properties has to do with potential oxidation during the homogenate preparation. In our study, as well as most similar type studies, the DTT, a sulfhydryl-reducing agent, was not added. Consequently, it would be expected that some oxidation would occur, possibly masking the actual changes that occurred with exercise. DTT was not added because of the possibility that the effects of exercise, if due to oxidation, would be reversed.
In this study, we have confirmed what has been reported on many previous occasions, namely that, with hypoxia (inspired O2 fraction = 0.14),
O2 peak is reduced compared with normoxia (15, 33). The
23% reduction that was observed in
O2 peak is consistent with what has been reported earlier in untrained subjects under similar conditions (20). We have also been able to demonstrate, again similar to previous studies (20), that, over a range of submaximal POs, compensatory adjustments allow OxPhos to remain similar or nearly similar to normoxia despite a lower arterial O2 saturation and arterial O2 content. Even at the highest PO, attained at fatigue in hypoxia, we could find no differences from normoxia when matched to the same PO. Some insight into these adjustments can be obtained from the minute ventilation and respiratory exchange ratio measurements, both of which were increased in hypoxia compared with normoxia at similar POs. Increased ventilation in conjunction with increased blood flow to working muscles appears important in minimizing the reductions in arterial O2 delivery in hypoxia (50, 51). Our results indicate that a substantial blunting of PO and
O2 peak can occur even though OxPhos is relatively well protected throughout submaximal exercise. This observation could suggest that fatigue may occur somewhat independently of a failure in ATP supply by OxPhos. Conceivably, fatigue could also prevent further increases in OxPhos (and
O2 peak) even though delivery, extraction, and utilization of O2 by mitochondria have not been fully exploited. Failure in E-C coupling as a cause of fatigue remains an inviting possibility in this regard.
To examine differences between normoxic and hypoxic conditions in Ca2+-cycling properties, it was not possible to use conventional two-way ANOVA procedures for repeated measures as a result of the unbalanced nature of our tissue-sampling schedule. Although the first exercise samples occurred at the same
O2 (and PO), this was not possible at the higher exercise intensities due to the randomization of conditions and ethical limitations in the number of biopsies that could be performed. To examine for differences between conditions, we have used regression analyses and slopes from the lines of best fit for the relationship between
O2 (or PO) and the property of interest. These plots clearly demonstrate a trend (P > 0.05) toward a greater effect of hypoxia on Ca2+ uptake and Ca2+ release. It should be emphasized that this approach using regression analyses depends on the assumption of linearity between the measured parameters and PO.
Although not measured in this study, reductions in the [Ca2+]f time integral remain a viable possibility to explain the inability to continue the progressive exercise task in both normoxia and hypoxia. Decreases in [Ca2+]f time integral could occur specifically as a consequence of decreases in Ca2+ release. Reductions in the Ca2+ time integral, mediated by decreases in Ca2+ release, have been previously shown to associate with fatigue in repetitively stimulated mouse muscle fibers (2). The fact that the depression in Ca2+ release was comparable to normoxia in hypoxia at fatigue, even though PO was considerably lower in hypoxia, is also suggestive that impaired Ca2+ cycling may be involved in the early fatigue observed during progressive exercise in this condition.
It must be emphasized that other, more central processes may be involved in the inability to continue progressive exercise. Because our measurements were conducted on homogenates under supposedly optimal in vitro conditions, the depression in Ca2+ release can be attributed directly to disturbances in the CRC. However, in vivo, other processes such as an inability of the sarcolemma and T tubule to conduct a repetitive action potential and/or a deficit in the mechanical signaling between the T tubule and the CRC could lead to reductions in Ca2+release (2). It should also be emphasized that with progressive exercise profound changes occur in the intracellular environment, which may impair Ca2+ cycling as well as a variety of other excitation and contraction processes (53). Consequently, isolating the direct site and process involved in fatigue during voluntary activity is not possible.
In summary, our results demonstrate that, during progressive exercise to fatigue in normoxia, disturbances in SR Ca2+ cycling occur as indicated by the in vitro measurements of Ca2+ uptake and Ca2+ release. With hypoxia, similar disturbances in Ca2+ cycling occur but at a reduced POpeak and
O2 peak. These findings raise the possibility that fatigue, both in normoxia and hypoxia with progressive exercise, is related to an inability to regulate the [Ca2+]f integral.
| GRANTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Amann, L. T. Proctor, J. J. Sebranek, D. F. Pegelow, and J. A. Dempsey Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans J. Physiol., January 1, 2009; 587(1): 271 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amann, L. T. Proctor, J. J. Sebranek, M. W. Eldridge, D. F. Pegelow, and J. A. Dempsey Somatosensory feedback from the limbs exerts inhibitory influences on central neural drive during whole body endurance exercise J Appl Physiol, December 1, 2008; 105(6): 1714 - 1724. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amann and J. A. Dempsey Reply from Markus Amann and Jerome A. Dempsey J. Physiol., April 1, 2008; 586(7): 2029 - 2030. [Full Text] [PDF] |
||||
![]() |
M. Amann and J. A. L. Calbet Convective oxygen transport and fatigue J Appl Physiol, March 1, 2008; 104(3): 861 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matsunaga, T. Mishima, T. Yamada, S. Inashima, and M. Wada Alterations in in vitro function and protein oxidation of rat sarcoplasmic reticulum Ca2+-ATPase during recovery from high-intensity exercise Exp Physiol, March 1, 2008; 93(3): 426 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Duhamel, H. J. Green, R. D. Stewart, K. P. Foley, I. C. Smith, and J. Ouyang Muscle metabolic, SR Ca2+-cycling responses to prolonged cycling, with and without glucose supplementation J Appl Physiol, December 1, 2007; 103(6): 1986 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Duhamel, R. D. Stewart, A. R. Tupling, J. Ouyang, and H. J. Green Muscle sarcoplasmic reticulum calcium regulation in humans during consecutive days of exercise and recovery J Appl Physiol, October 1, 2007; 103(4): 1212 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Romer, H. C. Haverkamp, M. Amann, A. T. Lovering, D. F. Pegelow, and J. A. Dempsey Effect of acute severe hypoxia on peripheral fatigue and endurance capacity in healthy humans Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R598 - R606. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amann, M. W. Eldridge, A. T. Lovering, M. K. Stickland, D. F. Pegelow, and J. A. Dempsey Arterial oxygenation influences central motor output and exercise performance via effects on peripheral locomotor muscle fatigue in humans J. Physiol., September 15, 2006; 575(3): 937 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amann, L. M. Romer, D. F. Pegelow, A. J. Jacques, C. J. Hess, and J. A. Dempsey Effects of arterial oxygen content on peripheral locomotor muscle fatigue J Appl Physiol, July 1, 2006; 101(1): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Romer, H. C. Haverkamp, A. T. Lovering, D. F. Pegelow, and J. A. Dempsey Effect of exercise-induced arterial hypoxemia on quadriceps muscle fatigue in healthy humans Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R365 - R375. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Holloway, H. J. Green, T. A. Duhamel, S. Ferth, J. W. Moule, J. Ouyang, and A. R. Tupling Muscle sarcoplasmic reticulum Ca2+ cycling adaptations during 16 h of heavy intermittent cycle exercise J Appl Physiol, September 1, 2005; 99(3): 836 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Sandiford, H. J. Green, T. A. Duhamel, J. D. Schertzer, J. D. Perco, and J. Ouyang Muscle Na-K-pump and fatigue responses to progressive exercise in normoxia and hypoxia Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R441 - R449. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |